Actively Recruiting
Creation of a Multicenter National Registry for Peripartum Cardiomyopathy.
Led by Federico II University · Updated on 2024-03-21
40
Participants Needed
1
Research Sites
116 weeks
Total Duration
On this page
Sponsors
F
Federico II University
Lead Sponsor
S
San Raffaele University Hospital, Italy
Collaborating Sponsor
AI-Summary
What this Trial Is About
Peripartum cardiomyopathy (PPCM) is a rare, severe and potentially life-threatening disorder of largely unknown etiology and pathophysiology, with unexplained geographical differences and heterogeneous presentation. Investigators hypothesize that a network-based multidisciplinary strategy integrating clinical and molecular phenotyping of PPCM patients might anticipate diagnosis, optimize treatments, and identify novel mechanisms to achieve the unmet goal of personalized medicine.
CONDITIONS
Official Title
Creation of a Multicenter National Registry for Peripartum Cardiomyopathy.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Development of heart failure signs or symptoms in the last month of pregnancy or within 5 months after delivery
- Left ventricle systolic dysfunction with LVEF less than 45% in the last month of pregnancy or within 5 months after delivery
You will not qualify if you...
- Presence of any identifiable cause of heart failure
- Recognizable heart disease before the last month of pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Federico II University Hospital
Naples, Italy, 80131
Actively Recruiting
Research Team
C
Cinzia Perrino
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here